Literature DB >> 27589873

Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease.

Xiao-Lu Niu1, Li Liu1, Zhi-Xiu Song1, Qing Li1, Zhi-Hua Wang1, Jian-Long Zhang1, He-Hua Li2.   

Abstract

Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities that could favor the occurrence of small intestinal bacterial overgrowth (SIBO). The aim of the study was to assess the prevalence of SIBO in Chinese patients with PD and the potential impact of SIBO on gastrointestinal symptoms and motor function. 182 consecutive Chinese patients with PD patients and 200 sex, age, and BMI-matched subjects without PD were included. All participants underwent the glucose breath test to assess SIBO. We examined the associations between factors and SIBO with logistic regression using SPSS. Fifty-five of the 182 PD patients were SIBO positive (30.2 %; 95 % CI 23.5-36.9 %) compared with 19 of 200 in the control group (9.5 %; 95 % CI 5.4-13.6 %); the difference was statistically significant (P < 0.0001; OR 4.13; 95 % CI 2.34-7.29). Motor fluctuations present was higher in the PD patients with SIBO than in the patients without SIBO (70.9 vs. 45.7 %; P = 0.002). Multivariate analysis showed that disease duration, Hoehn and Yahr stage, Unified PD Rating-III score, Unified PD Rating-IV score, and Non-Motor Symptoms Scale score were the factors associated with the SIBO-positive status in PD patients. SIBO was highly prevalent in PD, and nearly one-third was detected. SIBO was associated with worse gastrointestinal symptoms and worse motor function. Further studies are needed to specify the reasons underlying SIBO and worse motor function in PD.

Entities:  

Keywords:  Gastrointestinal dysfunction; Motor function; Parkinson’s disease; Small intestinal bacterial overgrowth

Mesh:

Year:  2016        PMID: 27589873     DOI: 10.1007/s00702-016-1612-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  25 in total

1.  Small-bowel bacterial overgrowth in diabetic subjects is associated with cardiovascular autonomic neuropathy.

Authors:  B Zietz; G Lock; R H Straub; B Braun; J Schölmerich; K D Palitzsch
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

2.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

3.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

4.  Small intestinal bacterial overgrowth in Parkinson's disease.

Authors:  Ai Huey Tan; Sanjiv Mahadeva; Abdul Malik Thalha; Peter R Gibson; Chiun Khang Kiew; Chia Ming Yeat; Sheang Wen Ng; Sheau Phing Ang; Siew Kian Chow; Chong Tin Tan; Hoi Sen Yong; Connie Marras; Susan H Fox; Shen-Yang Lim
Journal:  Parkinsonism Relat Disord       Date:  2014-03-02       Impact factor: 4.891

5.  Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.

Authors:  M Pierantozzi; A Pietroiusti; L Brusa; S Galati; A Stefani; G Lunardi; E Fedele; G Sancesario; G Bernardi; A Bergamaschi; A Magrini; P Stanzione; A Galante
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

6.  Prevalence of small intestinal bacterial overgrowth in Parkinson's disease.

Authors:  Maurizio Gabrielli; Patrizia Bonazzi; Emidio Scarpellini; Emanuele Bendia; Ernesto C Lauritano; Alfonso Fasano; Maria G Ceravolo; Marianna Capecci; Anna Rita Bentivoglio; Leandro Provinciali; Pietro A Tonali; Antonio Gasbarrini
Journal:  Mov Disord       Date:  2011-02-01       Impact factor: 10.338

Review 7.  Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits.

Authors:  Alan E Lomax; David R Linden; Gary M Mawe; Keith A Sharkey
Journal:  Auton Neurosci       Date:  2006-04-17       Impact factor: 3.145

Review 8.  Parkinson's disease: evidence for environmental risk factors.

Authors:  Karl Kieburtz; Kathryn B Wunderle
Journal:  Mov Disord       Date:  2012-10-24       Impact factor: 10.338

9.  Antimicrobial surveillance in idiopathic parkinsonism: indication-specific improvement in hypokinesia following Helicobacter pylori eradication and non-specific effect of antimicrobials for other indications in worsening rigidity.

Authors:  Sylvia M Dobbs; André Charlett; R John Dobbs; Clive Weller; Owens Iguodala; Cori Smee; Andrew J Lawson; David Taylor; Ingvar Bjarnason
Journal:  Helicobacter       Date:  2013-01-22       Impact factor: 5.753

Review 10.  Dysautonomia and cognitive dysfunction in Parkinson's disease.

Authors:  Werner Poewe
Journal:  Mov Disord       Date:  2007-09       Impact factor: 10.338

View more
  13 in total

1.  The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.

Authors:  Xiangming Wang; Yuehui Zhang; Chen Zhu; Guangzong Li; Jie Kang; Fang Chen; Ling Yang
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

2.  Hydrogen breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in autism.

Authors:  Li Wang; Yu-Mei Yu; You-Qi Zhang; Jie Zhang; Na Lu; Na Liu
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-08-10       Impact factor: 4.785

Review 3.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

Review 4.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

Review 5.  Autonomic Dysfunction in Parkinson's Disease.

Authors:  Ronald F Pfeiffer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 6.  Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis.

Authors:  Xiaoqing Li; Xin Feng; Zhongxiang Jiang; Zheng Jiang
Journal:  Gut Pathog       Date:  2021-04-16       Impact factor: 4.181

Review 7.  Intestinal Inflammation and Parkinson's Disease.

Authors:  Yu Li; Yuanyuan Chen; Lili Jiang; Jingyu Zhang; Xuhui Tong; Dapeng Chen; Weidong Le
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

8.  Small intestinal bacterial overgrowth in Alzheimer's disease.

Authors:  Karol Kowalski; Agata Mulak
Journal:  J Neural Transm (Vienna)       Date:  2021-11-19       Impact factor: 3.575

9.  Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.

Authors:  Satish S C Rao; Jigar Bhagatwala
Journal:  Clin Transl Gastroenterol       Date:  2019-10       Impact factor: 4.488

10.  Gut microbiota: a potential therapeutic target for Parkinson's disease.

Authors:  José Fidel Baizabal-Carvallo
Journal:  Neural Regen Res       Date:  2021-02       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.